RedHill Biopharma reported $584K in Gross Profit on Sales for its fiscal quarter ending in June of 2024.





Gross Profit On Sales Change Date
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Clal Biotechnology ILS -857K 1.42M Jun/2022
Compugen USD 63.8M 63.56M Dec/2025
Cronos Group USD 16.19M 34.52M Dec/2025
RedHill Biopharma USD 584K 0 Jun/2024